Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
J R Stanley
J R Stanley
Published May 1, 1989
Citation Information: J Clin Invest. 1989;83(5):1443-1448. https://doi.org/10.1172/JCI114036.
View: Text | PDF
Research Article

Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

  • Text
  • PDF
Abstract

Authors

J R Stanley

×

Total citations by year

Year: 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 Total
Citations: 1 3 6 3 3 9 1 2 3 4 5 1 3 5 1 3 7 2 6 2 1 7 6 5 10 3 7 10 10 15 10 5 3 1 1 164
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (164)

Title and authors Publication Year
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.
Kridin K, Mruwat N, Ludwig RJ
2022
Long-term experience with rituximab therapy for treatment-resistant moderate-to-severe pemphigus
BC Bozca, A Bilgiç, S Uzun
Journal of Dermatological Treatment 2021
Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies
W Zhao, J Wang, H Zhu, M Pan
Clinical Reviews in Allergy & Immunology 2021
Treatment of Pemphigus with Rituximab: Real-Life Experience in a Cohort of 117 Patients in Israel
A Nosrati, E Hodak, T Mimouni, M Oren-Shabtai, A Levi, YA Leshem, D Mimouni
Dermatology 2021
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab
SM Bhatia, RD Streilein, RP Hall, J Reddy
PloS one 2020
Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology
ML Fichtner, R Jiang, A Bourke, RJ Nowak, KC OConnor
Frontiers in immunology 2020
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first‐line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial
V Hébert, T Vermeulin, L Tanguy, B Tedbirt, C Mignard, J Bénichou, P Joly
British Journal of Dermatology 2020
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial
C Mignard, M Maho-Vaillant, ML Golinski, P Balayé, C Prost-Squarcioni, E Houivet, S Calbo, B Labeille, C Picard-Dahan, MP Konstantinou, G Chaby, MA Richard, JD Bouaziz, S Duvert-Lehembre, E Delaporte, P Bernard, F Caux, M Alexandre, S Ingen-Housz-Oro, P Vabres, G Quereux, A Dupuy, S Debarbieux, M Avenel-Audran, M DIncan, C Bédane, N Bénéton, D Jullien, N Dupin, L Misery, L Machet, M Beylot-Barry, O Dereure, B Sassolas, J Benichou, P Joly, V Hébert
JAMA DERMATOL 2020
Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study
F Li, Y Wu, W Bian, L Huang, X Zhu, X Chen, M Wang
Annals of clinical microbiology and antimicrobials 2020
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience
I Snast, L Spitzer, E Hodak, A Levi, D Mimouni, YA Leshem
Dermatology 2020
Ocular manifestations and management of autoimmune bullous diseases
S Feizi, D Roshandel
Journal of Ophthalmic and Vision Research 2019
Modifications of the Transcriptomic Profile of Autoreactive B Cells From Pemphigus Patients After Treatment With Rituximab or a Standard Corticosteroid Regimen
V Hébert, M Petit, M Maho-Vaillant, ML Golinski, G Riou, C Derambure, O Boyer, P Joly, S Calbo
Frontiers in immunology 2019
Assessment of the quality of life of Egyptian and Tunisian autoimmune bullous diseases’ patients using an Arabic version of the autoimmune bullous disease quality of life and the treatment of autoimmune bullous disease quality of life questionnaires
MA Saleh, I Zaraa, N Doss, NA Saleh, DF Murrell
Anais Brasileiros de Dermatologia 2019
Anti-Type VII Collagen Antibodies Are Identified in a Subpopulation of Bullous Pemphigoid Patients With Relapse
D Giusti, G Gatouillat, SL Jan, J Plée, P Bernard, F Antonicelli, BN Pham
Frontiers in immunology 2018
Rituximab therapy for refractory autoimmune bullous diseases: A multicenter, open-label, single-arm, phase 1/2 study on 10 Japanese patients
Y Kurihara, J Yamagami, T Funakoshi, M Ishii, J Miyamoto, Y Fujio, R Kakuta, A Tanikawa, Y Aoyama, K Iwatsuki, N Ishii, T Hashimoto, W Nishie, H Shimizu, K Kouyama, M Amagai
The Journal of Dermatology 2018
Investigation of the predisposing factor of pemphigus and its clinical subtype through a genome-wide association and next generation sequence analysis
Y Sun, H Liu, B Yang, C Wang, JN Foo, F Bao, A Irwanto, G Yu, X Fu, Z Wang, J You, J Liu, G Zhou, J Liu, F Zhang
Journal of the European Academy of Dermatology and Venereology 2018
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, F Caillot, ML Golinski, B Labeille, C Picard-Dahan, C Paul, MA Richard, JD Bouaziz, S Duvert-Lehembre, P Bernard, F Caux, M Alexandre, S Ingen-Housz-Oro, P Vabres, E Delaporte, G Quereux, A Dupuy, S Debarbieux, M Avenel-Audran, M D'Incan, C Bedane, N Bénéton, D Jullien, N Dupin, L Misery, L Machet, M Beylot-Barry, O Dereure, B Sassolas, T Vermeulin, J Benichou, P Musette
The Lancet 2017
Rituximab in pemphigus
V Hebert, P Joly
Immunotherapy 2017
Serum autoantibodies against epithelial cell adhesion molecules as disease biomarkers of eosinophilic esophagitis
ES Dellon, L Lin, R Beitia, TP Moran, Y Qian
Cell 2017
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases
S Yoshiji, T Murakami, S Harashima, R Ko, R Kashima, D Yabe, M Ogura, K Doi, N Inagaki
Journal of Diabetes Investigation 2017
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment
P Bernard, F Antonicelli
American Journal of Clinical Dermatology 2017
Augenbeteiligung beim Pemphigus vulgaris - retrospektive Studie an einer großen spanischen Kohorte: Augenbeteiligung beim Pemphigus vulgaris
A España, P Iranzo, J Herrero-González, JM Mascaro, R Suárez
Journal der Deutschen Dermatologischen Gesellschaft 2017
Ocular involvement in pemphigus vulgaris - a retrospective study of a large Spanish cohort: Ocular involvement in pemphigus vulgaris
A España, P Iranzo, J Herrero-González, JM Mascaro, R Suárez
Journal der Deutschen Dermatologischen Gesellschaft 2017
Autoantibodies to desmogleins 1 and 3 in patients with lichen planus
L Vahide, H Zahra, G Forugh, S Nazi
Archives of Dermatological Research 2017
Pemphigus : vers une réduction drastique de la corticothérapie grâce au rituximab
P Joly
Annales de Dermatologie et de Vénéréologie 2017
Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid
K Izumi, W Nishie, Y Mai, M Wada, K Natsuga, H Ujiie, H Iwata, J Yamagami, H Shimizu
Journal of Investigative Dermatology 2016
IgE autoantibodies in bullous pemphigoid: Supporting role, or leading player?
H Ujiie
Journal of Dermatological Science 2015
Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin
W Nishie, K Natsuga, H Iwata, K Izumi, H Ujiie, E Toyonaga, H Hata, H Nakamura, H Shimizu
The American Journal of Pathology 2015
Update on the pathogenesis of bullous pemphigoid: An autoantibody-mediated blistering disease targeting collagen XVII
W Nishie
Journal of Dermatological Science 2014
Opportunistic infections in patients with pemphigus
YA Leshem, M Gdalevich, M Ziv, M David, E Hodak, D Mimouni
Journal of the American Academy of Dermatology 2014
Susceptibility loci revealed for bovine respiratory disease complex in pre-weaned holstein calves
HL Neibergs, CM Seabury, AJ Wojtowicz, Z Wang, E Scraggs, JN Kiser, M Neupane, JE Womack, A Eenennaam, G Hagevoort, TW Lehenbauer, S Aly, J Davis, JF Taylor
BMC Genomics 2014
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
N Colliou, D Picard, F Caillot, S Calbo, SL Corre, A Lim, B Lemercier, BL Mauff, M Maho-Vaillant, S Jacquot, C Bedane, P Bernard, F Caux, C Prost, E Delaporte, MS Doutre, B Dreno, N Franck, S Ingen-Housz-Oro, O Chosidow, C Pauwels, C Picard, JC Roujeau, M Sigal, E Tancrede-Bohin, I Templier, R Eming, M Hertl, M D'Incan, P Joly, P Musette
Science Translational Medicine 2013
Neural nitric oxide synthase participates in pemphigus vulgaris acantholysis through upregulation of Rous sarcoma, mammalian target of rapamycin and focal adhesion kinase
A España, T Mòdol, MP Gil, MJ López-Zabalza
Experimental Dermatology 2013
Transition phénotypique d’un pemphigus vulgaire en pemphigus superficiel
C Lévy-Sitbon, Z Reguiaï, A Durlach, AL Goeldel, F Grange, P Bernard
Annales de Dermatologie et de Vénéréologie 2013
A prospective study on clinical response and cell-mediated immunity of pemphigus patients treated with rituximab
YA Leshem, M David, E Hodak, DA Waitman, D Vardy, M Israeli, M Eskin-Schwartz, R Bergman, D Mimouni
Archives of Dermatological Research 2013
Rituximab treatment of severe pemphigus: Long-term results including immunologic follow-up
Z Reguiai, T Tabary, M Maizières, P Bernard
Journal of the American Academy of Dermatology 2012
Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris : FAK in pemphigus vulgaris
MP Gil, T Modol, A España, MJ López-Zabalza
Experimental Dermatology 2012
Successful treatment of pemphigus with biweekly 1-g infusions of rituximab: A retrospective study of 47 patients
YA Leshem, E Hodak, M David, GJ Anhalt, D Mimouni
Journal of the American Academy of Dermatology 2012
Study of oral, ear, nose and throat involvement in pemphigus vulgaris by endoscopic examination: Pemphigus vulgaris and endoscopic examination
S Fernández, A España, M Navedo, L Barona
British Journal of Dermatology 2012
Anti-Skin Specific Autoantibodies Detected by a New Immunofluorescence Multiplex Biochip Method in Patients with Autoimmune Bullous Diseases
M Tampoia, A Zucano, D Villalta, A Antico, N Bizzaro
Dermatology 2012
Transgenic rescue of desmoglein 3 null mice with desmoglein 1 to develop a syngeneic mouse model for pemphigus vulgaris
T Hata, K Nishifuji, K Shimoda, T Sasaki, T Yamada, T Nishikawa, S Koyasu, M Amagai
Journal of Dermatological Science 2011
Homologous regions of heavy chain complementarity determining region 3 (H-CDR3) of pemphigus antibodies cause pathogenicity
Jun Yamagami, Aimee Payne, Stephen Kacir, Ken Ishii, Donald Siegel, John R. Stanley
Journal of Clinical Investigation 2010
Autoimmune Bullous Dermatoses in the Elderly: An Update on Pathophysiology, Diagnosis and Management
DF Mutasim
Drugs & Aging 2010
Autoimmune Bullous Dermatoses in the Elderly
DF Mutasim
Drugs & Aging 2010
Coagulation activation in autoimmune bullous diseases
AV Marzano, A Tedeschi, D Spinelli, D Fanoni, C Crosti, M Cugno
Clinical & Experimental Immunology 2009
An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris
M Pretel, A España, M Marquina, B Pelacho, JM López-Picazo, MJ López-Zabalza
Experimental Dermatology 2009
Netter's Internal Medicine
DS Rubenstein, LA Diaz
Netter's Internal Medicine 2009
Fortschritte der praktischen Dermatologie und Venerologie
T Ruzicka, H Wolff, P Thomas, J Prinz
2009
Life-Threatening Dermatoses and Emergencies in Dermatology
J Revuz, JC Roujeau, FA Kerdel, L Valeyrie-Allanore
2009
Diagnosis of Aging Skin Diseases
RA Norman
2008
Therapy of autoimmune bullous diseases
DF Mutasim
Therapeutics and Clinical Risk Management 2007
Ear, nose and throat manifestations in pemphigus vulgaris
A España, S Fernández, J Olmo, M Marquina, M Pretel, D Ruba, A Sánchez-Ibarrola
British Journal of Dermatology 2007
A Single Cycle of Rituximab for the Treatment of Severe Pemphigus
P Joly, H Mouquet, JC Roujeau, M D'Incan, D Gilbert, S Jacquot, ML Gougeon, C Bedane, R Muller, B Dreno, MS Doutre, E Delaporte, C Pauwels, N Franck, F Caux, C Picard, E Tancrede-Bohin, P Bernard, F Tron, M Hertl, P Musette
New England Journal of Medicine 2007
T cell control in autoimmune bullous skin disorders
M Hertl, R Eming, C Veldman
Journal of Clinical Investigation 2006
Are desmoglein autoantibodies essential for the immunopathogenesis of pemphigus vulgaris, or just ‘witnesses of disease'?
R Paus, M Amagai, AR Ahmed, Y Kitajima, JC Bystryn, Y Milner, R Gniadecki, M Hertl, C Pincelli, M Fridkis-Hareli, Y Aoyama, M Frušić-Zlotkin, E Müller, M David, D Mimouni, D Vind-Kezunovic, B Michel, M Mahoney, S Grando
Experimental Dermatology 2006
Establishment of the Mouse Model by Rabbit Antiserum Specific to EC1-2 or EC3-4 Epitopes for Studying the Pathogenesis of Pemphigus Vulgaris
M Pan, X Zhao, F Xue, W Li, J Zheng
Immunological Investigations 2006
Interferon-gamma down-regulates expression of the 230-kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS
T Kaneko, K Tamai, Y Matsuzaki, T Yamazaki, H Nakano, A Kon, I Hashimoto, K Hanada, Y Kaneda, J Uitto
Experimental Dermatology 2006
Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid
M Yoshida, T Hamada, M Amagai, K Hashimoto, R Uehara, K Yamaguchi, K Imamura, E Okamoto, S Yasumoto, T Hashimoto
Journal of Dermatological Science 2006
Commentary 3
M Hertl
Experimental Dermatology 2006
Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis—possible involvement of the EGF receptor
M Frušić-Zlotkin, D Raichenberg, X Wang, M Frušić-Zlotkin, D Raichenberg, X Wang, M David, B Michel, Y Milner
Autoimmunity 2006
Dermatologie und Venerologie
O Braun-Falco, G Plewig, HH Wolff, WH Burgdorf, M Landthaler
2005
Autoimmune Diseases of the Skin
M Hertl
2005
T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals
CM Veldman, KL Gebhard, W Uter, R Wassmuth, J Grötzinger, E Schultz, M Hertl
Journal of immunology (Baltimore, Md. : 1950) 2004
Environmental Risk Factors in Endemic Pemphigus Foliaceus (Fogo Selvagem)
V Aoki, RC Millikan, EA Rivitti, G Hans-Filho, DP Eaton, SJ Warren, N Li, J Hilario-Vargas, RG Hoffmann, LA Diaz
Journal of Investigative Dermatology Symposium Proceedings 2004
Evaluation of recombinant antigen-based assays for diagnosis of bullous autoimmune diseases
G D'Agosto, A Latini, M Carducci, A Mastroianni, A Vento, PC Fei
Clinical and diagnostic laboratory immunology 2004
In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades
I Sanchez-Carpintero, A Espana, B Pelacho, NL Moratalla, DS Rubenstein, LA Diaz, MJ Lopez-Zabalza
British Journal of Dermatology 2004
Management of autoimmune bullous diseases: Pharmacology and therapeutics
DF Mutasim
Journal of the American Academy of Dermatology 2004
Penfigoide gestacional: estudio de 9 casos
S Belmontea, SP González-Rodrígueza, CM Simóna, A Cuboa, LM Jiménez-Losaa, MA Ruiza, JL Lancharesa, LC Tejerizo-Lópeza, A Tejerizo-Garcíab
Clínica e Investigación en Ginecología y Obstetricia 2004
Keratinocyte Responsive Element 3: Analysis of a Keratinocyte-specific Regulatory Sequence in the 230-kDa Bullous Pemphigoid Antigen Gene Promoter
Y Matsuzaki, K Tamai, A Kon, D Sawamura, J Uitto, I Hashimoto
Journal of Investigative Dermatology 2003
Autoimmune Bullous Dermatoses in the Elderly: Diagnosis and Management
DF Mutasim
Drugs & Aging 2003
Tunisian endemic pemphigus foliaceus is associated with desmoglein 1 gene polymorphism
MB Ayed, P Martel, M Zitouni, D Gilbert, H Turki, M Mokni, AB Osman, MR Kamoun, A Zahaf, S Makni, H Masmoudi, F Tron
Genes and Immunity 2002
Paraneoplastic Pemphigus Sera React Strongly with Multiple Epitopes on the Various Regions of Envoplakin and Periplakin, Except for the C-Terminal Homologous Domain of Periplakin
Y Nagata, T Karashima, FM Watt, W Salmhofer, T Kanzaki, T Hashimoto
Journal of Investigative Dermatology 2001
A possible role of catenin dyslocalization in pemphigus vulgaris pathogenesis
LL Muzio, G Pannone, S Staibano, MD Mignogna, C Rubini, E Ruocco, GD Rosa, JJ Sciubba
Journal of Cutaneous Pathology 2001
Immunopathology of paraneoplastic pemphigus
T Hashimoto
Clinics in Dermatology 2001
Bullous pemphigoid sera react specifically with various domains of BP230, most frequently with C-terminal domain, by immunoblot analyses using bacterial recombinant proteins covering the entire molecule
T Hamada, Y Nagata, M Tomita, W Salmhofer, T Hashimoto
Experimental Dermatology 2001
General Themes in Cell–Cell Junctions and Cell Adhesion
R Eelkema, P Cowin
Tight Junctions 2001
Immunofluorescence in dermatology
DF Mutasim, BB Adams
Journal of the American Academy of Dermatology 2001
Immunology, Immunopathology, and Immunity
S Sell
2001
Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions in neonatal mice
Vu Thuong Nguyen, Assane Ndoye, Leonard D. Shultz, Mark R. Pittelkow, Sergei A. Grando
Journal of Clinical Investigation 2000
In Vitro and In Vivo Expression of Interleukin-1alpha and Tumor Necrosis Factor-alpha mRNA in Pemphigus Vulgaris: Interleukin-1alpha and Tumor Necrosis Factor-alpha are Involved in Acantholysis
C Feliciani, P Toto, P Amerio, SM Pour, G Coscione, P Amerio, G Shivji, B Wang, DN Sauder
Journal of Investigative Dermatology 2000
PRESENCE OF INTERLEUKIN 10 IN THE SERUM AND BLISTER FLUID OF PATIENTS WITH PEMPHIGUS VULGARIS AND PEMPHIGOID
K Bhol
Cytokine 2000
Novel human alpha9 acetylcholine receptor regulating keratinocyte adhesion is targeted by Pemphigus vulgaris autoimmunity
VT Nguyen, A Ndoye, SA Grando
The American Journal of Pathology 2000
Novel Human α9 Acetylcholine Receptor Regulating Keratinocyte Adhesion is Targeted by Pemphigus Vulgaris Autoimmunity
VT Nguyen, A Ndoye, SA Grando
The American Journal of Pathology 2000
Association of KM Genotype with Bullous Pemphigoid
G Raux, D Gilbert, P Joly, M Daveau, P Martel, M Christ, F Tron
Journal of Autoimmunity 2000
Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris
MG Mahoney, Z Wang, K Rothenberger, PJ Koch, M Amagai, JR Stanley
Journal of Clinical Investigation 1999
Common Human Leukocyte Antigen Alleles in Pemphigus Vulgaris and Pemphigus Foliaceus Italian Patients
ML Lombardi, O Mercuro, V Ruocco, AL Schiavo, V Lombari, V Guerrera, G Pirozzi, C Manzo
Journal of Investigative Dermatology 1999
HLA Class II Restriction of Autoreactive T Cell Responses in Pemphigus Vulgaris: Review of the Literature and Potential Applications for the Development of a Specific Immunotherapy
R Riechers, J Grötzinger, M Hertl
Autoimmunity 1999
Pemphigus Vulgaris and Pemphigus Foliaceus Antibodies are Pathogenic in Plasminogen Activator Knockout Mice
MG Mahoney, ZH Wang, JR Stanley
Journal of Investigative Dermatology 1999
Maladies bulleuses auto-immunes
P Joly
La Revue de Médecine Interne 1999
Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodies
K Bhol, S Tyagi, K Natarajan, N Nagarwalla, AR Ahmed
Journal of the European Academy of Dermatology and Venereology 1998
Potent T Cell Stimulatory Material with Antigenic Properties in Stratum Corneum of Normal Human Skin
JM Hales, RD Camp
Journal of Investigative Dermatology 1998
Affections dermatologiques de la muqueuse genitale masculine et de la verge
M Faure
Andrologie 1998
Paraneoplastic pemphigus in a dog
Lemmens, de Bruin, De Meulemeester, Wyder, Suter
Veterinary Dermatology 1998
Recurrent pemphigus vulgaris limited to the surgical area after mastectomy
S Shirahama, F Furukawa, M Takigawa
Journal of the American Academy of Dermatology 1998
The Human Complement System in Health and Disease
J Ahearn, A Rosengard
The Human Complement System in Health and Disease 1998
Novel non-radioisotope immunoprecipitation studies indicate involvement of pemphigus vulgaris antigen in paraneoplastic pemphigus
T Hashimoto, M Amagai, W Ning, T Nishikawa, T Karashima, O Mori, S Jablonska, T P Chorzelski
Journal of Dermatological Science 1998
Recognition of Desmoglein 3 by Autoreactive T Cells in Pemphigus Vulgaris Patients and Normals
M Hertl, M Amagai, H Sundaram, J Stanley, K Ishii, SI Katz
Journal of Investigative Dermatology 1998
Molecular Biological Aspects of Acquired Bullous Diseases
E Dabelsteen
Critical Reviews in Oral Biology & Medicine 1998
A Review of Methods Available for the Identification of Both Organ-Specific and Non-Organ-Specific Autoantibodies
J Miles, P Charles, P Riches
Annals of Clinical Biochemistry 1998
A complementarity-determining region peptide of an anti-desmosome autoantibody may interact with the desmosomal plaque through molecular mimicry with a cytoplasmic desmoglein 1 sequence
D Gilbert, P Courville, F Brard, P Joly, S Petit, E Bernardi, AR Schoofs, P Lauret, F Tron
European Journal of Immunology 1997
Do Certain Autoantibodies Produced in the Course of Human Autoimmune Blistering Skin Diseases Behave as Adhesion Molecules?
D Gilbert, F Brard, P Courville, P Joly, P Lauret, F Tron
Annals of the New York Academy of Sciences 1997
Oral pemphigus: Clinical significance of esophageal involvement
MD Mignogna, LL Muzio, G Galloro, RA Satriano, V Ruocco, E Bucci
Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology 1997
Specific detection of anti-cell surface antibodies in herpes gestationis sera
T Hashimoto, M Amagai, H Murakami, M Higashiyama, K Hashimoto, T Nishikawa
Experimental Dermatology 1996
Pemphigus Vulgaris Antigen (Desmoglein 3) Is Localized in the Lower Epidermis, the Site of Blister Formation in Patients
M Amagai, PJ Koch, T Nishikawa, JR Stanley
Journal of Investigative Dermatology 1996
Pemphigus vulgaris in distant relatives of two families: association with major histocompatibility complex class II genes
K Bhol, J Yunis, AR Eahmed
Clinical and Experimental Dermatology 1996
The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen
K Matsumura, M Amagai, T Nishikawa, T Hashimoto
Archives of Dermatological Research 1996
Curvicircular intracytoplasmic membranous structures in keratinocytes of pemphigus foliaceus
J Tada, K Hashimoto
Journal of Cutaneous Pathology 1996
Molecular analysis of HLA DRB1 and DQB1 in Italian patients with pemphigus vulgaris
ML Lombardi, O Mercuro, G Tecame, C Fusco, V Ruocco, A Salerno, G Pirozzi, C Manzo
Tissue Antigens 1996
Altered thrombomodulin staining in blistering dermatoses
DE Jackson, CA Mitchell, G Masons, HH Salem, JA Hayman
Pathology 1996
Intramuscular gold therapy for young patients with pemphigus vulgaris: a prospective, open, clinical study utilizing a dermatologist/rheumatologist team approach
PG Sutej, JL Jorizzo, W White
Journal of the European Academy of Dermatology and Venereology 1995
In Situ-Bound Antibodies Eluted From the Skin of Patients with Bullous Pemphogoid Are Preferentially Directed Against the 230-kD Bullous Pemphigoid Antigen
NJ Korman
Journal of Investigative Dermatology 1995
Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Foliaceus
M Amagai, T Hashimoto, KJ Green, N Shimizu, T Nishikawa
Journal of Investigative Dermatology 1995
Autoantibodies to desmoplakin I and II in patients with erythema multiforme
D Foedinger, GJ Anhalt, B Boecskoer, A Elbe, K Wolff, K Rappersberger
Journal of Experimental Medicine 1995
Adhesion Molecules. I: Keratinocyte-Keratinocyte Interactions; Cadherins and Pemphigus
M Amagai
Journal of Investigative Dermatology 1995
Study on an antibody against F1F2 fragment of human factor V in a patient with Hashimoto's disease and bullous pemphigoid
E Suehisa, M Toku, N Akita, R Fushimi, T Takano, H Tada, Y Iwatani, N Amino
Thrombosis Research 1995
Atypical pemphigus associated with monoclonal IgA gammopathy
S Miyagawa, T Hashimoto, H Ohno, A Nakagawa, K Watanabe, T Nishikawa, T Shirai
Journal of the American Academy of Dermatology 1995
Interferon--mediated Inactivation of Transcription of the 230-kDa Bullous Pemphigoid Antigen Gene (BPAG1) Provides Novel Insight into Keratinocyte Differentiation
K Tamai, K Li, S Silos, L Rudnicka, T Hashimoto, T Nishikawa, J Uitto
The Journal of biological chemistry 1995
Tissue-specific Expression of the 230-kDa Bullous Pemphigoid Antigen Gene ( BPAG1 ): IDENTIFICATION OF A NOVEL KERATINOCYTE REGULATORY cis -ELEMENT KRE3
K Tamai, SA Silos, K Li, E Korkeela, H Ishikawa, J Uitto
The Journal of biological chemistry 1995
The epidermolytic (exfoliative) toxins of Staphylococcus aureus
CJ Bailey, BP Lockhart, MB Redpath, TP Smith
Medical Microbiology and Immunology 1995
Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus
M Amagai, T Hashimoto, N Shimizu, T Nishikawa
Journal of Clinical Investigation 1994
Mouse 230-kDa Bullous Pemphigoid Antigen Gene: Structural and Functional Characterization of the 5'-Flanking Region and Interspecies Conservation of the Deduced Amino-Terminal Peptide Sequence of the Protein
D Sawamura, T Sato, A Kon, K Harada, K Nomura, I Hashimoto, K Tamai, J Uitto
Journal of Investigative Dermatology 1994
HLA-DQA1, -DQB1 and -DRB1 genotyping in Japanesepemphigus vulgarispatients by the PCR-RFLP method
H Niizeki, H Inoko, N Mizuki, N Inamoto, K Watababe, T Hashimoto, T Nishikawa
Tissue Antigens 1994
Overlapping Distribution of Autoantibody Specificities in Paraneoplastic Pemphigus and Pemphigus Vulgaris
P Joly, E Thomine, D Gilbert, S Verdier, A Delpech, C Prost, C Lebbe, P Lauret, F Tron
Journal of Investigative Dermatology 1994
Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris
A Firooz, A Mazhar, AR Ahmed
Journal of the American Academy of Dermatology 1994
Childhood bullous pemphigoid: Immunohistochemical, immunoelectron microscopic, and Western blot analysis
T Nagano, M Tani, A Adachi, T Takanaga, S Sakamoto, S Kodama, S Fujiwara
Journal of the American Academy of Dermatology 1994
Autoantibodies against Cell Adhesion Molecules in Pemphigus
M Amagai
The Journal of Dermatology 1994
Pemphigus Vulgaris Associated with Autoimmune Hemolytic Anemia and Elevated TNFα
M Ujihara, S Hamanaka, S Matsuda, F Numa, H Kato
The Journal of Dermatology 1994
Expression of laminin, type IV procollagen and 230 kDa bullous pemphigoid antigen genes by keratinocytes and fibroblasts in culture: application of the polymerase chain reaction for detection of small amounts of messenger RNA
K Nomura, T Sugawara, T Sato, D Sawamura, I Hashimoto, Y Sugita, J Uitto
Archives of Dermatological Research 1994
Identification of a DNA-binding protein (keratinocyte transcriptional protein-1) recognizing a keratinocyte-specific regulatory element in the 230-kDa bullous pemphigoid antigen gene
K Tamai, K Li, J Uitto
The Journal of biological chemistry 1994
PHYSICALLY INDUCED PEMPHIGUS AFTER COSMETIC PROCEDURES
RP Kaplan, SP Detwiler, HW Saperstein
International Journal of Dermatology 1993
Desmosomes and hemidesmosomes
DR Garrod
Current Opinion in Cell Biology 1993
Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes
S Kárpáti, M Amagai, R Prussick, K Cehrs, JR Stanley
The Journal of Cell Biology 1993
Immunofluorescence and Immunoelectron Microscopy Analyses of a Human Monoclonal Anti-Epithelial Cell Surface Antibody that Recognizes a 185-kD Polypeptide: A Component of the Paraneoplastic Pemphigus Antigen Complex?
P Joly, D Gilbert, E Thomine, A Delpech, S Verdier, P Lauret, F Tron
Journal of Investigative Dermatology 1993
IgG Antibodies from Patients with Bullous Pemphigoid Bind to Fusion Proteins Encoded by BPAg1 cDNA
JE Miller, MJ Rico, RP Hall
Journal of Investigative Dermatology 1993
Cellular origin of the dermal-epidermal basement membrane
MP Marinkovich, DR Keene, CS Rimberg, RE Burgeson
Developmental Dynamics 1993
Paraneoplastic pemphigus in a child with a T-cell lymphoblastic lymphoma
M Rybojad, T Leblanc, B Flageul, P Bernard, P Morel, G Schaison, MF D'agay, L Borrador
British Journal of Dermatology 1993
PEMPHIGUS VULGARIS ASSOCIATED WITH SPINDLE CELL THYMOMA
DL Norris, MS Saywell, GM Strutton, GJ Stephenson
Australasian Journal of Dermatology 1993
Skin diseases
BR Hughes
Reviews in Clinical Gerontology 1993
Pathology of Domestic Animals
IK Barker, AV Dreumel, N Palmer
Pathology of Domestic Animals 1993
Detection and partial characterization of ocular cicatricial pemphigoid antigens on COLO and SCaBER tumor cell lines
A Mohimen, R Neumann, CS Foster, AR Ahmed
Current Eye Research 1993
Non-Infectious Diseases of the Oral Soft Tissue: a New Approach
DM Williams
Advances in dental research 1993
Inherited Epidermolysis Bullosa: Clinical Features, Molecular Genetics, and Pathoetiologic Mechanisms
J Uitto, AM Christiano
Dermatologic Clinics 1993
Drug-Induced Pemphigus
DF Mutasim, NJ Pelc, GJ Anhalt
Dermatologic Clinics 1993
Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5‘-end of the gene and the 3‘-untranslated region of the mRNA
K Li, K Tamai, EM Tan, J Uitto
The Journal of biological chemistry 1993
Human autoantibodies against desmoplakins in paraneoplastic pemphigus
JR Oursler, RS Labib, L Ariss-Abdo, T Burke, EJ O'Keefe, GJ Anhalt
Journal of Clinical Investigation 1992
Molecular genetics of the cutaneous basement membrane zone. Perspectives on epidermolysis bullosa and other blistering skin diseases
J Uitto, AM Christiano
Journal of Clinical Investigation 1992
Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic
M Amagai, S Karpati, R Prussick, V Klaus-Kovtun, JR Stanley
Journal of Clinical Investigation 1992
Immunomorphologic and Biochemical Identification of the Pemphigus Foliaceous Autoantigen Within Desmosomes
K Rappersberger, N Roos, JR Stanley
Journal of Investigative Dermatology 1992
230-kD and 180-kD Bullous Pemphigoid Antigens Are Distinct Gene Products
D Saweamura, DK Li, J Uitto
Journal of Investigative Dermatology 1992
The biology and clinical application of systemic glucocorticoids
SR Feldman
Current Problems in Dermatology 1992
Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy
PJ Lamey, TD Rees, WH Binnie, JM Wright, KV Rankin, NB Simpson
Oral Surgery, Oral Medicine, Oral Pathology 1992
The Autoimmune Diseases II
CC Bernard, TE Mandel, IR Mackay
The Autoimmune Diseases II 1992
The interleukin-2 receptor in lesions and serum of bullous pemphigoid
D Zillikens, A Ambach, M Schuessler, R Dummer, AA Hartmann, G Burg
Archives of Dermatological Research 1992
Recent advances on the 180-kDa epidermal antigen in autoimmune subepidermal bullous skin diseases
P Bernard
Springer Seminars in Immunopathology 1992
Structure and antigenicity of the skin basement membrane zone
JD Fine
Journal of Cutaneous Pathology 1991
Bullous Pemphigoid Antigen: cDNA Cloning, Cellular Expression, and Evidence for Polymorphism of the Human Gene
D Sawamura, KH Li, K Nomura, Y Sugita, AM Christiano, J Uitto
Journal of Investigative Dermatology 1991
Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes
WG Carter, MC Ryan, PJ Gahr
Cell 1991
HLA class II antigens are associated with Japanese pemphigus patients
H Niizeki, H Inoko, H Narimatsu, H Takata, A Sonoda, T Tadakuma, A Ando, K Tsuji, T Hashimoto, T Nishikawa
Human Immunology 1991
Comparison of molecularly cloned bullous pemphigoid antigen to desmoplakin I confirms that they define a new family of cell adhesion junction plaque proteins
T Tanaka, DA Parry, V Klaus-Kovtun, PM Steinert, JR Stanley
The Journal of biological chemistry 1991
The role of ligand-receptor interactions in disease
BJ Vermeer, JA Leuven
Journal of Dermatological Science 1990
Dermatology
MH Rustin
Postgraduate medical journal 1990
Distinct functions for integrins alpha 3 beta 1 in focal adhesions and alpha 6 beta 4/bullous pemphigoid antigen in a new stable anchoring contact (SAC) of keratinocytes: relation to hemidesmosomes
WG Carter, P Kaur, SG Gil, PJ Gahr, EA Wayner
The Journal of Cell Biology 1990
Vesiculobullous mucocutaneous disease: pemphigus vulgaris
DM Williams
Journal of Oral Pathology and Medicine 1989
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts